Nanostructured lipid carriers for topical delivery of an anti-acne drug: characterization and ex vivo evaluation
CYP1A1 metabolism of estrogen, polyaromatic hydrocarbons, and more CYP1A2 metabolism of caffeine, duloxetine, bupropion, aflatoxin B, and more CYP2A6 metabolism of nicotine, coumarin, and more CYP2B6 metabolism of ketamine, methadone, sertraline, and more CYP2C9 metabolism of warfarin, rosuvastatin, celecoxib, and more CYP2C19 metabolism of clopidogrel, some proton pump inhibitors, more CYP2D6 metabolism of some antidepressants, antipsychotics, more CYP3A4 metabolism of half of all prescription drugs CYP2E1 metabolism of fatty acids, alcohol, and some anesthetics Phase II detoxification genes: UGT, GST, Nrf2 Phase II detoxification involves taking the metabolites of phase I and modifying them to be easily excreted through conjugation with sulfur, glutathione, glucuronic acid, amino acids, or methyl groups
J.GuptaS
10.1155/2018/1027152 11 MoreauR.JalanR.GinesP.PavesiM.AngeliP.CordobaJ.et al (2013)
They exhibit caring and attention to detail you normally don't find
The pharma world is watching closely, and patients will be the biggest winners as competitors like Pfizer, Roche, and Merck enter the ring
